Factors affecting response variables with emphasis on drug release and loading for optimization of liposomes

References

• Hu C-M, Aryal S, Zhang L. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv. 2010;1(2):323–334. doi: 10.4155/tde.10.13.
   PubMedGoogle Scholar
• Pande S. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artif Cells Nanomed Biotechnol. 2023;51(1):428–440. doi: 10.1080/21691401.2023.2247036.
   PubMed Web of Science ®Google Scholar
• Ta T, Porter T. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release. 2013;169(1-2):112–125. doi: 10.1016/j.jconrel.2013.03.036.
   PubMed Web of Science ®Google Scholar
• Affram K, Udofot O, Cat A, et al. In vitro and in vivo antitumor activity of gemcitabine loaded thermosensitive liposomal nano­particles and mild hyperthermia in pancreatic cancer. Int J Adv Res. 2015;3(10):859–874.
   PubMedGoogle Scholar
• Nogueira E, Gomes A, Preto A, et al. Design of liposomal formulations for cell targeting. Colloids Surf, B. 2015;136:514–526. doi: 10.1016/j.colsurfb.2015.09.034.
   PubMed Web of Science ®Google Scholar
• Nsairat H, Khater D, Sayed U, et al. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5):e09394. doi: 10.1016/j.heliyon.2022.e09394.
   PubMed Web of Science ®Google Scholar
• Xu Y, Meng H. Paclitaxel-loaded stealth liposomes: development, characterization, pharmacokinetics and biodistribution, artificial cells. Nanomedicine and Biotechnology. 2014;44:350–355.
   Web of Science ®Google Scholar
• Ashley J, Quinlan C, Schroeder V, et al. Dual carfilzomib and doxorubicin-loaded liposomal nanoparticles for synergistic efficacy in multiple myeloma. Mol Cancer Ther. 2016;15:9.
   Web of Science ®Google Scholar
• Calvagno G, Celia C, Paolino D, et al. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Curr Drug Deliv. 2007;4(1):89–101. doi: 10.2174/156720107779314749.
   PubMedGoogle Scholar
• Chang H, Yeh M. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed. 2012;7:49–60.
   PubMed Web of Science ®Google Scholar
• Zylberberg C, Matosevic S. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug Deliv. 2016;23(9):3319–3329. doi: 10.1080/10717544.2016.1177136.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: classification, preparation and applications. Nanoscale Res Lett. 2013;8(1):102. doi: 10.1186/1556-276X-8-102.
   PubMed Web of Science ®Google Scholar
• Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27(4):1372. doi: 10.3390/molecules27041372.
   PubMed Web of Science ®Google Scholar
• Kan P, Tsao CW, Wang AJ, et al. A liposomal formulation able to incorporate a high content of paclitaxel and exert promising anticancer effect. J Drug Deliv. 2011;2011:629234. doi: 10.1155/2011/629234.
   PubMedGoogle Scholar
• Eleftheriou K, Kaminari A, Panagiotaki K, et al. A combination drug delivery system employing thermosensitive liposomes for enhanced cell penetration and improved in vitro efficacy. Int J Pharm. 2020;574:118912. doi: 10.1016/j.ijpharm.2019.118912.
   PubMedGoogle Scholar
• Lila A, Ishida T. Liposomal delivery systems: design optimization and current applications. Biol Pharm Bull. 2017;40(1):1–10. doi: 10.1248/bpb.b16-00624.
   PubMed Web of Science ®Google Scholar
• Eras A, Castillo D, Suárez M, et al. Chemical conjugation in drug delivery systems. Front Chem. 2022;10:889083. doi: 10.3389/fchem.2022.889083.
   PubMed Web of Science ®Google Scholar
• Zoghi A, Khosravi-Darani K, Omri A. Process variables and design of experiments in liposome and nanoliposome research. Mini-Rev Med Chem. 2016;16(1):16.
   Google Scholar
• Pamunuwa G, Karunaratne V, Nedra Karunaratne D. Effect of lipid composition on in vitro release and skin deposition of curcumin encapsulated liposomes. J Nanomater. 2016;2016:1–9. doi: 10.1155/2016/4535790.
   Web of Science ®Google Scholar
• Miao ZL, Deng YJ, Du HY, et al. Preparation of a liposomal delivery system and its in vitro release of rapamycin. Exp Ther Med. 2015;9(3):941–946. doi: 10.3892/etm.2015.2201.
   PubMed Web of Science ®Google Scholar
• Yingchoncharoen P, Kalinowski D, Richardson D. Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol Rev. 2016;68(3):701–787. doi: 10.1124/pr.115.012070.
   PubMed Web of Science ®Google Scholar
• Pereira S, Egbu R, Jannati G, et al. Docetaxel-loaded liposomes: the effect of lipid composition and purification on drug encapsulation and in vitro toxicity. Int J Pharm. 2016;514(1):150–159. doi: 10.1016/j.ijpharm.2016.06.057.
   PubMed Web of Science ®Google Scholar
• Briuglia ML, Rotella C, McFarlane A, et al. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 2015;5(3):231–242. doi: 10.1007/s13346-015-0220-8.
   PubMed Web of Science ®Google Scholar
• Tsotas VA, Mourtas S, Antimisiaris SG. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability. Drug Deliv. 2007;14(7):441–445. doi: 10.1080/10717540701603530.
   PubMed Web of Science ®Google Scholar
• Cadena P, Pereira M, Cordeiro R, et al. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta. 2013;1828(2):309–316.
   PubMed Web of Science ®Google Scholar
• Ramana LN, Sethuraman S, Ranga U, et al. Development of a liposomal nanodelivery system for nevirapine. J Biomed Sci. 2010;17(1):57. doi: 10.1186/1423-0127-17-57.
   PubMedGoogle Scholar
• Joseph J, B N VH, D RD. Experimental optimization of Lornoxicam liposomes for sustained topical delivery. Eur J Pharm Sci. 2018;112:38–51. doi: 10.1016/j.ejps.2017.10.032.
   PubMed Web of Science ®Google Scholar
• Wehbe M, Malhotra A, Anantha M, et al. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer. J Controlled Release. 2017;252:50–61. doi: 10.1016/j.jconrel.2017.03.010.
   PubMed Web of Science ®Google Scholar
• Saraswat AL, Maher TJ. Development and optimization of stealth liposomal system for enhanced in vitro cytotoxic effect of quercetin. J Drug Delivery Sci Technol. 2020;55:101477. doi: 10.1016/j.jddst.2019.101477.
   Web of Science ®Google Scholar
• Rathod S, Deshpande SG. Design and evaluation of liposomal formulation of pilocarpine nitrate. Indian J Pharm Sci. 2010;72(2):155–160. doi: 10.4103/0250-474X.65014.
   PubMed Web of Science ®Google Scholar
• Muppidi K, Pumerantz A, Wang J, et al. Development and stability studies of novel liposomal vancomycin formulations. ISRN Pharm. 2012;2012:636743–636748. doi: 10.5402/2012/636743.
   PubMedGoogle Scholar
• Tamam H, Park J, Gadalla HH, et al. Development of liposomal gemcitabine with high drug loading capacity. Mol Pharm. 2019;16(7):2858–2871. doi: 10.1021/acs.molpharmaceut.8b01284.
   PubMed Web of Science ®Google Scholar
• Mehanna M, El-Kader N, Samaha M. Liposomes as potential carriers for ketorolac ophthalmic delivery: formulation and stability issues. Braz J Pharm Sci. 2017;53(2):10. doi: 10.1590/s2175-97902017000216127.
   Web of Science ®Google Scholar
• Chountoulesi M, Naziris N, Pippa N, et al. The significance of drug-to-lipid ratio to the development of optimized liposomal formulation. J Liposome Res. 2018;28(3):249–258.
   PubMed Web of Science ®Google Scholar
• Lasic DD, Papahadjopoulos D. Liposomes revisited. Science. 1995;267(5202):1275–1276. doi: 10.1126/science.7871422.
   PubMed Web of Science ®Google Scholar
• Bulbake U, Doppalapudi S, Kommineni N, et al. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9(2):12. doi: 10.3390/pharmaceutics9020012.
   PubMed Web of Science ®Google Scholar
• Aghaei H, Solaimany Nazar A, Varshosaz J. Double flow focusing microfluidic-assisted based preparation of methotrexate–loaded liposomal nanoparticles: encapsulation efficacy, drug release and stability. Colloids Surf, A. 2021;614:126166. doi: 10.1016/j.colsurfa.2021.126166.
   Google Scholar
• Ailiesei I, Anuta V, Mircioiu C, et al. Application of statistical design of experiments for the optimization of clodronate loaded liposomes for oral administration. Rev Chim. 2016;67:1566–1570.
   Web of Science ®Google Scholar
• Miatmoko A, Salim H, Zahro S, et al. Dual loading of primaquine and chloroquine into liposome. Eur Pharm J. 2019;66(2):18–25. doi: 10.2478/afpuc-2019-0009.
   Google Scholar
• Johnston M, Semple S, Klimuk S, et al. Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim Biophys Acta. 2006;1758(1):55–64. doi: 10.1016/j.bbamem.2006.01.009.
   PubMed Web of Science ®Google Scholar
• Vali A, Toliyat T, Shafaghi B, et al. Preparation, optimization and characterization of topotecan loaded PEGylated liposomes using factorial design. Drug Dev Ind Pharm. 2008;34(1):10–23. doi: 10.1080/03639040701385055.
   PubMed Web of Science ®Google Scholar
• Sailor G, Seth A, Parmar G, et al. Formulation and in vitro evaluation of berberine containing liposome optimized by 32 full factorial designs. J App Pharm Sci. 2015;5(7):023–028. doi: 10.7324/JAPS.2015.50704.
   Google Scholar
• Handali S, Moghimipour E, Rezaei M, et al. A novel 5-Fluorouracil targeted delivery to Colon cancer using folic acid conjugated liposomes. Biomed Pharmacoth. 2018;108:1259–1273. doi: 10.1016/j.biopha.2018.09.128.
   PubMed Web of Science ®Google Scholar
• Mahira S, Kommineni N, Husain G, et al. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: a new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomed Pharmacoth. 2019;110:803–817. doi: 10.1016/j.biopha.2018.11.145.
   PubMed Web of Science ®Google Scholar
• Soema P, Willems G, Jiskoot W, et al. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. Eur J Pharm Biopharm. 2015;94:427–435. doi: 10.1016/j.ejpb.2015.06.026.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Das PJ, Dey S, et al. Development and optimization of besifloxacin hydrochloride loaded liposomal gel prepared by thin film hydration method using 32 full factorial design. Colloids Surf, A. 2019;585:124071. doi: 10.1016/j.colsurfa.2019.124071.
   Google Scholar
• Jangde R, Singh D. Preparation and optimization of quercetin-loaded liposomes for wound healing, using response surface methodology. Artif Cells Nanomed Biotechnol. 2016;44(2):635–641. doi: 10.3109/21691401.2014.975238.
   PubMed Web of Science ®Google Scholar
• Yuan J, Qin F, Tu J, et al. Preparation, characterization, and anti­oxidant activity evaluation of liposomes containing water-Soluble hydroxytyrosol from olive. Molecules. 2017;22(6):870–815. doi: 10.3390/molecules22060870.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu M, Wang H, et al. Increased cutaneous wound healing effect of biodegradable liposomes containing madecassoside: preparation, optimization, in vitro dermal permeation, and in vivo bioevaluation. Int J Nanomedicine. 2016;11:2995–3007. doi: 10.2147/IJN.S105035.
   PubMed Web of Science ®Google Scholar
• Permana A, Tekko I, McCrudden M, et al. Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. J Controlled Release. 2019;316:34–52. doi: 10.1016/j.jconrel.2019.10.004.
   PubMed Web of Science ®Google Scholar
• Singh M, Pindiprolu S, Sanapalli B, et al. Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: in vitro studies. RSC Adv. 2019;9(43):24987–24994. doi: 10.1039/c9ra04814f.
   PubMed Web of Science ®Google Scholar
• Listik E. Development and optimization of G-1 polymeric nanoparticulated and liposomal systems for Central nervous system applications. Neurol Disord Therap. 2018;2(1):1–5. doi: 10.15761/NDT.1000125.
   Google Scholar
• Tefas L, Sylvester B, Tomuta Sesarman A, et al. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach. Drug Des Devel Ther. 2017;11:1605–1621. doi: 10.2147/DDDT.S129008.
   PubMed Web of Science ®Google Scholar
• Vakili-Ghartavol R, Rezayat SM, Faridi-Majidi R, et al. Optimization of docetaxel loading conditions in liposomes: proposing potential products for metastatic breast carcinoma chemotherapy. Sci Rep. 2020;10(1):5569–5514. doi: 10.1038/s41598-020-62501-1.
   PubMed Web of Science ®Google Scholar
• Kannan V, Balabathula P, Divi M, et al. Optimization of drug loading to improve physical stability of paclitaxel-loaded long-circulating liposomes. J Liposome Res. 2015;25(4):308–315. doi: 10.3109/08982104.2014.995671.
   PubMed Web of Science ®Google Scholar
• Sadarani B, Majumdar A, Paradkar S, et al. Enhanced skin permeation of methotrexate from penetration enhancer containing vesicles: in vitro optimization and in vivo evaluation. Biomed Pharmcothe. 2019;114:13.
   Web of Science ®Google Scholar
• Liu J, Wang Z, Li F, et al. Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: characterization and evaluation. Asian J Pharm Sci. 2015;10(3):212–222. doi: 10.1016/j.ajps.2014.12.004.
   Web of Science ®Google Scholar
• Lakhani P, Patil A, Wu K, et al. Optimization, stabilization and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Int J Pharm. 2019;572:118771–118714. doi: 10.1016/j.ijpharm.2019.118771.
   PubMed Web of Science ®Google Scholar
• González-Rodríguez ML, Barros LB, Palma J, et al. Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. Int J Pharm. 2007;337(1-2):336–345. ISSN 0378-5173. doi: 10.1016/j.ijpharm.2007.01.024.
   PubMed Web of Science ®Google Scholar
• Jain A, Hurkat P, Jain S. Development of liposomes using formulation by design: basics to recent advances. Chem Phys Lipids. 2019;224:104764. doi: 10.1016/j.chemphyslip.2019.03.017.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145–160. doi: 10.1038/nrd1632.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48. doi: 10.1016/j.addr.2012.09.037.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Doxil®–the first FDA-approved nano-drug: lessons learned. J Controlled Release. 2012;160(2):117–134. doi: 10.1016/j.jconrel.2012.03.020.
   PubMed Web of Science ®Google Scholar
• Saito T, Ishido K, Kudo D, et al. Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer. Mol Clin Oncol. 2017;6(6):963–967. doi: 10.3892/mco.2017.1251.
   PubMedGoogle Scholar
• Wolfram J, Suri K, Huang Y, et al. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells. J Microencapsul. 2014:31 (5):501-507.
   PubMed Web of Science ®Google Scholar
• Ahmad H, Arya A, Agrawal S, et al. Chapter 19- Novel lipid nanostructures for delivery of natural agents with antioxidant, anti-inflammatory and antistroke potential: perspectives and outcomes. Micro Nano Technol, 2017;577–605.
   Google Scholar
• Jin J, Teng C, Li T. Combination therapy versus gemcitabine monotherapy in the treatment of elderly pancreatic cancer: a meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2018;12:475–480. doi: 10.2147/DDDT.S156766.
   PubMed Web of Science ®Google Scholar
• Zhen S, Qiang R, Lu J, et al. CRISPR/Cas9-HPV-liposome enhances antitumor immunity and treatment of HPV infection-associated cervical cancer. J Med Virol. 2022;95:e28144.
   PubMed Web of Science ®Google Scholar
• Nsairat H, Alshaer W, Odeh F, et al. Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. OpenNano. 2023;11:100132. doi: 10.1016/j.onano.2023.100132.
   Google Scholar